Vaxart's total assets for Q2 2025 were $164.09M, an increase of 3.49% from the previous quarter. VXRT total liabilities were $131.21M for the fiscal quarter, a 16.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.